In this issue:
- Tumor debulking + chemotherapy in multiorgan mCRC
- Transanal total mesorectal excision-combined robot-assisted surgery for rectal cancer
- Time between neoadjuvant chemoradiotherapy and surgery and rectal cancer outcomes
- Real-world outcomes of pembrolizumab in advanced anal cancer
- ART after local excision of anal SCC
- Retifanlimab + carboplatin-paclitaxel in first-line advanced anal SCC
- Circulating tumour DNA and efficacy of celecoxib in colon cancer
- Comorbidities and outcomes in patients with colon or rectal cancer
- Survival prognosis of early- and later-onset colorectal cancer
- Neoadjuvant chemotherapy vs upfront surgery in locally advanced colon cancer
Please login below to download this issue (PDF)